DOCA Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Doca, and when can generic versions of Doca launch?
Doca is a drug marketed by Organon Usa Inc and is included in one NDA.
The generic ingredient in DOCA is desoxycorticosterone acetate. There are two drug master file entries for this compound. Additional details are available on the desoxycorticosterone acetate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for DOCA?
- What are the global sales for DOCA?
- What is Average Wholesale Price for DOCA?
Summary for DOCA
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 90 |
| Patent Applications: | 3,945 |
| DailyMed Link: | DOCA at DailyMed |
US Patents and Regulatory Information for DOCA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Organon Usa Inc | DOCA | desoxycorticosterone acetate | INJECTABLE;INJECTION | 001104-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
